A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
Categories (click each to see list of all clinical trials associated with that category): FPBCC CTO Studies, Head & Neck (ONC)
Current Status: Open
Phase: II
Principal Investigator: Abughanimeh, Omar
Contact Information:
Cindy McWilliams
+1 402-559-8155
cimcwilliams@unmc.edu
Eligibility: https://clinicaltrials.gov/study/NCT07062354?term=NCT07062354&rank=1
Summary